In finance, there are all sorts of arcane acronyms, many of which float below the radar screen of normal life until all of a sudden they’re important and interesting. Almost no one had heard of an SPE ...

Canaan shares were 14% higher, at $1.41, after the company said it was halting its current at-the-market offering program. The company established a new ATM equity offering program on Oct. 24, to ...

NiSource Inc. (NYSE: NI) (“NiSource”, “we” and “our”) announced today that it has established an “at-the-market” equity offering program under which NiSource may sell shares of its common stock, par ...

MIAMI--(BUSINESS WIRE)--$SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the expansion of its Phase III clinical ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Inventiva ( (IVA)) has shared an ...

Access to additional capital further strengthens Digital Asset Treasury execution strategy Preferred converts to common stock at $250 per Caliber share SCOTTSDALE, Ariz., Sept. 17, 2025 (GLOBE ...

Forward Industries (FORD), a publicly-traded design and manufacturing firm that’s building out a solana SOL $142.22 treasury, has filed a $4 billion at-the-market (ATM) equity offering program with ...

NEW YORK--(BUSINESS WIRE)--Forward Industries, Inc. (NASDAQ: FORD) (the "Company" or “Forward Industries”), the leading Solana treasury company, today announced that it has filed an automatic shelf ...

Nasdaq-listed company Forward Industries filed for an at-the-market (ATM) equity offering program of up to $4 billion, giving the company flexibility to sell shares over time to support its ...

Getting cash from an ATM is growing increasingly expensive as fees reach record highs. Americans are now paying an average of $4.86 for out-of-network ATM withdrawals, up 1.9% from $4.77 last year, ...

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company, today announced that it has filed a prospectus ...